Brief: IX Biopharma Enters Term Sheet For Proposed Joint Venture
10/11/2025 01:30
Nov 10 (Reuters) - IX Biopharma Ltd IXBI.SI: TERM SHEET FOR PROPOSED JOINT VENTURE TO ESTABLISH MANUFACTURING AND COMMERCIALISATION BASE IN USA NON-BINDING TERM SHEET WITH ORION SPECIALTY LABS Further company coverage: IXBI.SI ((Reuters.Briefs@thomsonreuters.com;))
Recent news on IX Biopharma
See all newsBrief: IX Biopharma Says Co Will Undertake An Internal Restructuring Of Its Consumer Business
Brief: IX Biopharma To Issue 1 MLN New Shares To Anson Properties At S$0.4215 Per Share
Brief: IX Biopharma Says US Government Awards US$41 MLN Contract To Fund Development Of Wafermine
Brief: IX Biopharma To Raise At Least S$6 MLN Via Placement At S$0.198 Per Share
Brief: IX Biopharma Enters Term Sheet For Proposed Joint Venture